Literature DB >> 27516359

Validity of diagnostic codes for identifying cutaneous squamous cell carcinoma in The Health Improvement Network.

Z C Chiesa Fuxench1, A B Troxel2, J M Gelfand1,2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 27516359      PMCID： PMC5303691          DOI： 10.1111/bjd.14957

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  9 in total

1.  Validity of The Health Improvement Network (THIN) for the study of psoriasis.

Authors:  N M Seminara; K Abuabara; D B Shin; S M Langan; S E Kimmel; D Margolis; A B Troxel; J M Gelfand
Journal:  Br J Dermatol       Date:  2011-02-03       Impact factor: 9.302

2.  Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study.

Authors:  A Dregan; H Moller; T Murray-Thomas; M C Gulliford
Journal:  Cancer Epidemiol       Date:  2012-06-21       Impact factor: 2.984

3.  Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.

Authors:  Howard W Rogers; Martin A Weinstock; Steven R Feldman; Brett M Coldiron
Journal:  JAMA Dermatol       Date:  2015-10       Impact factor: 10.282

4.  Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network.

Authors:  Alexis Ogdie; Sara Alehashemi; Thorvardur Jon Love; Yihui Jiang; Kevin Haynes; Sean Hennessy; Hyon Choi; Joel M Gelfand
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-07-05       Impact factor: 2.890

5.  Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.

Authors:  I Marcil; R S Stern
Journal:  Arch Dermatol       Date:  2000-12

Review 6.  A systematic review of worldwide incidence of nonmelanoma skin cancer.

Authors:  A Lomas; J Leonardi-Bee; F Bath-Hextall
Journal:  Br J Dermatol       Date:  2012-05       Impact factor: 9.302

7.  Validation of THIN data for non-melanoma skin cancer.

Authors:  Andy Meal; Jo Leonardi-Bee; Chris Smith; Richard Hubbard; Fiona Bath-Hextall
Journal:  Qual Prim Care       Date:  2008

8.  Cancer incidence in The Health Improvement Network.

Authors:  Kevin Haynes; Kimberly A Forde; Rita Schinnar; Patricia Wong; Brian L Strom; James D Lewis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-08       Impact factor: 2.890

Review 9.  Epidemiology and economic burden of nonmelanoma skin cancer.

Authors:  Burak Ömür Cakir; Peter Adamson; Cemal Cingi
Journal:  Facial Plast Surg Clin North Am       Date:  2012-11       Impact factor: 1.918
  9 in total
  1 in total

1.  Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink.

Authors:  Youjin Wang; Ruth M Pfeiffer; Rotana Alsaggaf; Wilhelmine Meeraus; Julia C Gage; Lesley A Anderson; Renée C Bremer; Nikoletta Nikolenko; Hanns Lochmuller; Mark H Greene; Shahinaz M Gadalla
Journal:  Int J Cancer       Date:  2017-11-20       Impact factor: 7.396
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.